LPIN1 Induces Gefitinib Resistance in EGFR Inhibitor-Resistant Non-Small Cell Lung Cancer Cells

SIMPLE SUMMARY: Here, we attempted to identify targets that could be used to overcome resistance toward epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC). To accomplish this, we chose LPIN1 among the candidate targets that were identified from a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Jung Hee, You, Yeon-Mi, Koo, Han, Lee, Dong Chul, Yeom, Young Il, Park, Kyung Chan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102170/
https://www.ncbi.nlm.nih.gov/pubmed/35565351
http://dx.doi.org/10.3390/cancers14092222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102170/
https://www.ncbi.nlm.nih.gov/pubmed/35565351
http://dx.doi.org/10.3390/cancers14092222

Ejemplares similares